Yüklüyor......
Evaluating the safety and tolerability of inpatient sacubitril/valsartan initiation in a community hospital
BACKGROUND: Sacubitril/valsartan has been incorporated into guidelines based on the results of the PARADIGM-HF trial, which demonstrated reduced mortality in stable patients with heart failure with reduced ejection fraction (HFrEF). Sacubitril/valsartan is recommended in addition to other HF therapi...
Kaydedildi:
| Yayımlandı: | J Community Hosp Intern Med Perspect |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Taylor & Francis
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7034425/ https://ncbi.nlm.nih.gov/pubmed/32128057 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/20009666.2019.1708638 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|